State-of-the-Art Symposium
Venous and Arterial Thrombosis: Recent Advances in Biology and Therapy
The second in a series of cutting-edge symposia offered by the American Society of Hematology.
April 9-10, 2005
San Francisco Marriott
San Francisco, CA
MEETING REGISTRATION
Only a limited attendance will be permitted to register for this popular interactive, small-group event. Participants may register for the meeting one of two ways:
Register online using our secure registration site with your Mastercard or Visa.
Complete the mail-in registration form for American Express or Check payments.
PROGRAM DESCRIPTION
This intensive, clinically focused course will use a combination of didactic lectures and case studies to provide you with the latest advances in the prevention and treatment of venous and arterial thrombosis. Internationally renowned speakers with backgrounds in hematology, cardiology, and vascular medicine, including generalists and specialists, will cover topics such as antithrombotic drugs, venous thromboembolism, percutaneous interventions, atherothrombosis, acute coronary syndromes, and peripheral arterial disease. The inclusion of case presentations in a small group setting will encourage interactions between faculty and attendees, as well as provide an opportunity to apply this new knowledge in a clinical setting. The complete agenda, hotel information, CME information, and other details can be found in the symposium brochure.
Course faculty include:
Jeffrey Weitz, M.D., FRCP(C), FACP, FCCP
McMaster University
Symposium Chair
Bruce Furie, M.D.
Harvard Medical School/BI-Deaconess Medical Center
Sam Schulman, M.D., Ph.D.
McMaster University/Karolinska Institute
Shannon Bates, M.D., MSc, FRCP(C)
McMaster University Medical Centre
Jack Hirsh, M.D., CM, FRCP(C), FRACP, FRSC, DSc
McMaster University/Henderson Research Centre
Anthony J. Comerota, M.D., FACS
Jobst Vascular Center
Peter Libby, M.D.
Harvard Medical School/Brigham and Women's Hospital
David R. Phillips, Ph.D.
Portola Pharmaceuticals Inc.
Alison Schecter, M.D., FACC
Mount Sinai School of Medicine
Pierre Theroux, M.D.
Montreal Heart Institute and University of Montreal
Michael D. Ezekowitz, M.D., Ph.D.
Drexel University College of Medicine
Michael R. Jaff, D.O., FACP, FACC
Massachusetts General Hospital
Mark A. Creager, M.D.
Harvard Medical School/Brigham and Women's Hospital
Timothy M. Sullivan, M.D.
Mayo Clinic
TARGET AUDIENCE
This course is designed for hematologists, internists, cardiologists, vascular medicine specialists, and vascular surgeons. Residents and fellows are also welcome to attend.
Should you have questions about the course content or its logistics, please contact the American Society of Hematology at 202-776-0544 or cme@hematology.org.
SUPPORT
The American Society of Hematology is grateful to Amgen Oncology, Genentech BioOncology/Biogen Idec BioOncology, and Sanofi-Aventis for being Lead Commercial Supporters of this ASH State-of-the-Art-Symposium.
The following exhibitors will be on hand at this State-of-the-Art Symposium:
- Amgen Oncology
- Genentech BioOncology/Biogen Idec
- GlaxoSmithKline
- Ortho Biotech
- Pfizer
- Sanofi-Aventis
ASH would like to acknowledge the many individuals involved in the program planning process. In addition to the invited session chairs and speakers, the ASH State-of-the-Art Symposium, Venous and Arterial Thrombosis: Recent Advances in Biology and Therapy, would not be possible without the creativity and hard work of the following ASH members who have generously volunteered their time to put together this outstanding program. Special thanks are due to:
Jeffrey Weitz, M.D. (Program Chair)
McMaster University
Hamilton, Ontario, Canada
James N. George, M.D.
University of Oklahoma
Health Sciences Center
Oklahoma City, OK
Kimberly W. Schlesinger, M.D.
University of Pittsburgh Medical Center
Pittsburgh, PA
Daniel Weisdorf, M.D.
University of Minnesota
Minneapolis, MN
Michael E. Williams, M.D.
University of Virginia School of Medicine
Charlottesville, VA